Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Axon Enterprise Inc., 3 years.
Axon Enterprise Inc.
Director
Haemonetics Corporation
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Haemonetics Corporation July 24, 202698.5%
-
Haemonetics Corporation July 24, 202597.5%
-
Haemonetics Corporation July 25, 202498.1%
-
Haemonetics Corporation August 4, 202398.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 24, 2026 | Haemonetics Corporation | Grant or award | +2,538 | — | — |
| Nov 10, 2025 | Haemonetics Corporation | Open-market purchase | +1,400 | $70.56 | $98,784 |
| Jul 24, 2025 | Haemonetics Corporation | Grant or award | +2,693 | — | — |
| Jul 25, 2024 | Haemonetics Corporation | Grant or award | +2,207 | — | — |
| Aug 4, 2023 | Haemonetics Corporation | Grant or award | +2,226 | — | — |
| May 12, 2023 | Axon Enterprise Inc. | Grant or award | +993 | — | — |
| Mar 7, 2023 | Axon Enterprise Inc. | Open-market sale | −92 | $220.85 | $20,318 |
| Mar 7, 2023 | Axon Enterprise Inc. | Open-market sale | −3,457 | $220.72 | $763,029 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.